Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers.

导出 LinkOut

翻译打印收藏纠错

作者： Maria H,Mehlum ^[1] ; Knut,Liestøl ^[2] ; Sverre E,Kjeldsen ^[3] ; Torgeir B,Wyller ^[4] ; Stevo,Julius ^[2] ; Peter M,Rothwell ^[5] ; Giuseppe,Mancia ^[1] ; Gianfranco,Parati ^[2] ; Michael A,Weber ^[5] ; Eivind,Berge ^[6]

作者单位： From the Department of Geriatric Medicine (M.H.M., T.B.W.), Oslo University Hospital Ullevaal, Oslo, Norway. ^[1] Institute of Clinical Medicine (M.H.M., S.E.K., T.B.W.), University of Oslo, Norway. ^[2] Department of Informatics (K.L.), University of Oslo, Norway. ^[3] Department of Cardiology (S.E.K., E.B.), Oslo University Hospital Ullevaal, Oslo, Norway. ^[4] Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (S.E.K., S.J.). ^[5] Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, United Kingdom (P.M.R.). ^[6] Policlinico di Monza, Monza, Italy (G.M.). ^[7] University of Milano-Bicocca, Milan, Italy (G.M., G.P.). ^[8] Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital, Milan, Italy (G.P.). ^[9] Department of Cardiovascular Medicine, State University of New York, Downstate College of Medicine (M.A.W.). ^[10]

关键词 blood pressure variability blood pressure- lowering drugs heart failure hypertension myocardial infarction stroke